Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL.
Eur Respir J. 2020 Jul 7;56(1):2000535. doi: 10.1183/13993003.00535-2020. Print 2020 Jul.
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL.
Clin Infect Dis. 2020 Aug 14;71(4):e1-e36. doi: 10.1093/cid/ciaa241.
Mycobacterium kansasii.
Johnston JC, Chiang L, Elwood K.
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0011-2016.
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL.
Clin Infect Dis. 2020 Aug 14;71(4):905-913. doi: 10.1093/cid/ciaa1125.
Hypercalcaemia in Mycobacterium kansasii pulmonary infection.
Flowers RC, Ocampo J, Krautbauer J, Kupin WL.
BMJ Case Rep. 2021 Nov 30;14(11):e245800. doi: 10.1136/bcr-2021-245800.
Severe Disseminated Mycobacterium kansasii Infection due to Autoantibodies Against IFN-.
Pan C, Dong Z, Zhang W, Wang F, Wang H.
J Clin Immunol. 2023 Jan;43(1):76-79. doi: 10.1007/s10875-022-01362-x. Epub 2022 Sep 3.
Prosthetic Knee Joint Infection Caused by Mycobacterium kansasii.
Dasari SP, Hadro AE, Singh R, Neilson JC.
J Am Acad Orthop Surg Glob Res Rev. 2022 Apr 7;6(4):e21.00183. doi: 10.5435/JAAOSGlobal-D-21-00183.
Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome.
Smith MB, Molina CP, Schnadig VJ, Boyars MC, Aronson JF.
Arch Pathol Lab Med. 2003 May;127(5):554-60. doi: 10.5858/2003-127-0554-PFOMKI.
Disseminated Mycobacterium kansasii infection due to surgical site infection following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
Sekiguchi E, Kurosawa S, Iketani Y, Yoshimura Y, Nakazato T.
Int J Infect Dis. 2024 Sep;146:107123. doi: 10.1016/j.ijid.2024.107123. Epub 2024 Jun 3.
Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.
Guan Y, Bai D, Wang C, Liu Y.
AIDS Res Hum Retroviruses. 2021 Mar;37(3):171-172. doi: 10.1089/aid.2020.0141. Epub 2020 Nov 10.
